Assistant Professor, Family Medicine, Macon, Mercer University School of Medicine
    Internal Medicine
  
  
  Urviben Patel works in the field of Internal Medicine. She studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare.  She received awards:"CMS Meaningful Use Stage 1 Certification".  Urviben Patel accepts Medicare payments and is listed with Medicare.gov.
    
    
    
    
  Doctors Specialties
  
  
  Accepted Insurances
  
  
    Awards
    
    
        - CMS Meaningful Use Stage 1 Certification
 
    
    Education
    
    
        - 
          
 University of Alabama Medical Center 
        - 
          
 B. J. Medical College Ahmedabad 
    
    Drug Facts
    
    
      
        | NPI NUMBER | 
          | 
        1306053731  | 
      
      
        | NPPES Provider LastName | 
          | 
        PATEL  | 
      
      
        | NPPES Provider FirstName | 
          | 
        URVIBEN  | 
      
      
        | NPPES Provider ZIPCode | 
          | 
        312012102  | 
      
      
        | NPPES Provider State | 
          | 
        GA  | 
      
      
        | Specialty Description | 
          | 
        Internal Medicine  | 
      
      
        | Total Claim Count | 
          | 
        823.0  | 
      
      
        | Distinct Opioid Count | 
          | 
        3.0  | 
      
      
        | Opioid Claim Count | 
          | 
        59.0  | 
      
      
        | Percent Opioid Claims | 
          | 
        7.17  | 
      
    
  Helpful Reviews
  
  
  Give
    Anonymous Review
    
    
    
    
    
    Medicare Facts
    
    
      
        | National Provider Identifier [NPI] | 
        1306053731  | 
      
      
        | Last Name Of The Provider | 
        PATEL  | 
      
      
        | First Name Of The Provider | 
        URVIBEN  | 
      
      
        | View All | 
         | 
      
    
    Similar Doctors
    
    
  
  
    
    
    
    
Doctor Directory | TOS | twitter | FB | Angel | blog